Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus
The Bruton tyrosine kinase inhibitor ibrutinib has become a leading therapy against chronic lymphoid leukemia. Recently, ibrutinib has been associated with the occurrence of invasive fungal infections, in particular invasive aspergillosis. The mechanisms underlying the increased susceptibility to fu...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2020-02-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/9532 |